You're bloated. You're exhausted. You're "soft" even though the scale keeps dropping. If that sounds familiar, the compound isn't the problem — your monitoring is.
To be clear up front: this isn't a push to go source retatrutide and start cranking dosage. If anything, reliance on this compound has gotten ahead of itself across the peptide space. This article isn't about pushing more reta — it's about what almost nobody using it is actually tracking.
Why This Happens
Retatrutide is a triple agonist — GIP, GLP-1, and glucagon receptor activity in one molecule — which makes it one of the most metabolically aggressive compounds available right now. That potency is exactly why running it without a baseline is a problem. Most of the "side effects" people report on reta aren't side effects of the drug itself. They're downstream signs that nobody pulled labs before starting, and nobody's been watching them since.
If you sourced this through a generic research-use-only site and started dosing without bloodwork, you don't have a reta problem. You have a monitoring problem.
The Lab Panel You Actually Need
Run a full panel before starting, and again every 6–8 weeks — whether you're running an aggressive protocol or just microdosing long-term. Screenshot this.
Above this signals liver cell damage.
Reflects overall liver stress.
Typically the earliest marker to rise with liver strain.
Baseline pancreatic activity.
Earliest indicator of pancreatic dysfunction. Above 300, stop immediately and seek care.
Above this suggests bile duct backup and liver swelling; above 2 is a serious flag.
Above this can indicate early cholestasis.
Total-body inflammation marker. If you're running peptides, this number matters.
Elevated alongside rising amylase/lipase points toward pancreatic inflammation, not a random infection.
| Marker | Target Range | What It Tells You |
|---|---|---|
| ALT | < 40 | Liver Function |
| AST | < 35 | Liver Function |
| GGT | < 50 | Liver Function |
| Amylase | < 100 | Pancreatic Function |
| Lipase | < 100 | Pancreatic Function — Stop & seek care if > 300 |
| Total Bilirubin | < 1 | Bilirubin |
| Direct Bilirubin | < 0.7 | Bilirubin |
| CRP | < 0.5 | Inflammatory & Immune |
| WBC | 4.5 – 8.5 | Inflammatory & Immune |
The Real Rule — Monitoring Cadence
Run this panel every 6–8 weeks. Not "when something feels off." Not "if I remember." On a schedule, regardless of dosing strategy — aggressive titration or long-term microdosing, the cadence is the same.
And if the lab cost is the thing making you hesitate before you spend on the compound itself — that's the signal. Peptide therapy isn't a casual purchase, and it isn't the right priority if monitoring isn't part of the budget from day one.
How Prime Wellness Rx Approaches This Differently
This is exactly why our retatrutide protocols are physician-supervised from the start — baseline panels, scheduled re-testing, and a provider actually reviewing the numbers, not just shipping product. If you're already running reta without this in place, that's worth a conversation before your next cycle.
This article is for educational purposes and is not a substitute for individualized medical care. Prime Wellness Rx patients work directly with licensed prescribers for dosing, titration, and lab review.
Don't run retatrutide blind.
Our physician-supervised protocols include baseline labs and scheduled re-testing so you actually know what's happening under the hood. Pair it with our Whole Genome Sequencing ($899) for a complete metabolic picture before your next cycle.